We are live on
!
Find out more
iShares US Medical Devices ETF
581 hedge funds and large institutions have $2.33B invested in iShares US Medical Devices ETF in 2024 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 163 increasing their positions, 229 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
110% more call options, than puts
Call options by funds: $45.7M | Put options by funds: $21.7M
37% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 49
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
1% more funds holding
Funds holding: 574 → 581 (+7)
1% less capital invested
Capital invested by funds: $2.36B → $2.33B (-$31.9M)
3.39% less ownership
Funds ownership: 43.91% → 40.52% (-3.4%)
29% less repeat investments, than reductions
Existing positions increased: 163 | Existing positions reduced: 229
Holders
581
Holders Change
+7
Holders Change %
+1.22%
% of All Funds
8.37%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
67
Increased
163
Reduced
229
Closed
49
Calls
$45.7M
Puts
$21.7M
Net Calls
+$24M
Net Calls Change
+$1.33M
Top Buyers
| 1 |
Citigroup
New York
|
+$293M |
| 2 |
Barclays
London,
United Kingdom
|
+$19.6M |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$10.7M |
| 4 |
Goldman Sachs
New York
|
+$10.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.3M |
